Guided Therapeutics (OTCMKTS:GTHP) Stock Price Down 13.8% – Here’s Why

Guided Therapeutics Inc. (OTCMKTS:GTHP)’s stock price dropped 13.8% during trading on Monday . The company traded as low as $0.4295 and last traded at $0.4295. Approximately 21,013 shares were traded during mid-day trading, an increase of 15% from the average daily volume of 18,311 shares. The stock had previously closed at $0.4980.

Guided Therapeutics Trading Down 13.8%

The business has a fifty day moving average price of $0.36 and a two-hundred day moving average price of $0.29. The firm has a market capitalization of $37.10 million, a PE ratio of -8.59 and a beta of 0.49.

Guided Therapeutics (OTCMKTS:GTHP) last issued its quarterly earnings data on Thursday, November 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.06 million for the quarter.

About Guided Therapeutics

Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non‐invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.

The company secured 510(k) clearance from the U.S.